SMAD4 and neoplasm: Before injection of PACO2 SMAD4-GFP cells, FACS analysis revealed that ∼97% of the cells were positive for the expression of the transgenic construct, and it is likely that the negative fraction of modified cell populations induced the tumor engraftment in a few mice.